NOCIL DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.78×0.73×0.90×0.74×0.74×
1.35×1.66×1.36×1.27×1.03×
5.0%3.5%6.0%9.8%12.2%
0.63×0.63×0.68×0.75×0.88×
1.21×1.19×1.17×1.19×1.20×
4.0%3.2%5.9%8.2%9.7%
3.2%3.2%5.9%8.2%10.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NOCIL₹145.35

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹2,428 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.740.900.730.78
Interest Burden (Pretax/EBIT) ×1.031.271.361.661.35
EBIT Margin %12.199.856.023.525.00
Asset Turnover ×0.880.750.680.630.63
Financial Leverage (Assets/Equity) ×1.201.191.171.191.21
ROE (5-step product, year-end total equity) %9.718.195.863.204.04
ROE (owners' profit / average owners' equity) %9.958.185.943.153.15
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.